Blue Trust Inc. Purchases 814 Shares of C3.ai, Inc. $AI

Blue Trust Inc. increased its position in shares of C3.ai, Inc. (NYSE:AI) by 53.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,329 shares of the company’s stock after acquiring an additional 814 shares during the quarter. Blue Trust Inc.’s holdings in C3.ai were worth $57,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Garde Capital Inc. bought a new position in C3.ai during the 1st quarter worth approximately $29,000. NewEdge Advisors LLC boosted its stake in C3.ai by 48.7% during the 1st quarter. NewEdge Advisors LLC now owns 2,442 shares of the company’s stock worth $51,000 after acquiring an additional 800 shares during the last quarter. Optimum Investment Advisors boosted its stake in C3.ai by 35.6% during the 1st quarter. Optimum Investment Advisors now owns 2,668 shares of the company’s stock worth $56,000 after acquiring an additional 700 shares during the last quarter. McElhenny Sheffield Capital Management LLC bought a new position in C3.ai during the 2nd quarter worth approximately $71,000. Finally, Family Legacy Financial Solutions LLC bought a new position in C3.ai during the 2nd quarter worth approximately $103,000. Institutional investors own 38.96% of the company’s stock.

C3.ai Trading Down 2.0%

Shares of AI opened at $17.70 on Friday. The company has a market cap of $2.44 billion, a price-to-earnings ratio of -6.81 and a beta of 1.96. C3.ai, Inc. has a 1-year low of $14.70 and a 1-year high of $45.08. The company’s fifty day simple moving average is $17.53 and its 200 day simple moving average is $21.54.

C3.ai (NYSE:AI) last issued its earnings results on Wednesday, September 3rd. The company reported ($0.86) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.65). C3.ai had a negative return on equity of 40.69% and a negative net margin of 92.08%.The firm had revenue of $70.26 million for the quarter, compared to analyst estimates of $104.02 million. During the same quarter in the previous year, the firm posted ($0.05) earnings per share. C3.ai’s quarterly revenue was down 19.4% on a year-over-year basis. C3.ai has set its Q2 2026 guidance at EPS. As a group, research analysts forecast that C3.ai, Inc. will post -2.44 earnings per share for the current year.

Insiders Place Their Bets

In other C3.ai news, EVP Robert David Schilling sold 470,420 shares of C3.ai stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $17.29, for a total transaction of $8,133,561.80. Following the completion of the transaction, the executive vice president directly owned 1,011,327 shares of the company’s stock, valued at $17,485,843.83. The trade was a 31.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Hitesh Lath sold 46,881 shares of C3.ai stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $16.99, for a total transaction of $796,508.19. Following the transaction, the chief financial officer directly owned 209,154 shares of the company’s stock, valued at approximately $3,553,526.46. This trade represents a 18.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,661,106 shares of company stock valued at $48,255,922 over the last ninety days. 26.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on AI shares. Oppenheimer reissued a “market perform” rating on shares of C3.ai in a research note on Tuesday, August 12th. KeyCorp dropped their target price on shares of C3.ai from $18.00 to $10.00 and set an “underweight” rating on the stock in a report on Thursday, September 4th. JMP Securities dropped their target price on shares of C3.ai from $30.00 to $24.00 and set a “market outperform” rating on the stock in a report on Thursday, September 4th. Weiss Ratings restated a “sell (d-)” rating on shares of C3.ai in a report on Wednesday, October 8th. Finally, UBS Group raised their target price on shares of C3.ai from $16.00 to $17.00 and gave the stock a “neutral” rating in a report on Friday, September 12th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, seven have given a Hold rating and five have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and an average target price of $22.09.

About C3.ai

C3.ai, Inc operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information.